News Flow8 May 2019 15:34
Important date for me is the 11th of July as I expect next results to be annouced just before then.
Forward looking news Items
: hRPC for Retinal Disease Deals being discussed: Encouraged by the level of interest other potential collaborators are showing in all of our programs. We look forward to continuing to advance our clinical and business development activities in the months ahead. Timeline. Possible at any point but wording suggests nothing straight away
hRPC for Retinal Disease . The Company expects to treat the final six patients of the study this summer and to report data from all 12 of the Phase 2a subjects in the second half of this calendar year. Timeline: We know the 2nd cohort have been dosed and they report in 60 day results which line up with next line item.
Chinese Deal: Likely they report when payments are made no idea on timelines but 6 million is due.
Finance Results: announced a year-end business update ahead of its preliminary results for the year ended March 31, 2019, which will be announced on Thursday, July 11, 2019 which will be done in front of Analysts.
: Exosome Technology Deals being discussed: ReNeuron is in active discussions with other commercial third parties regarding potential collaboration agreements for the Company´s exosome technology. Timeline: anytime is possible but suggests should expect sooner rather than latter
• : CTX for stroke disability: Delayed on results until 2nd half of 2020 basically on back of Chinese deal. A game changer in itself but of limited interest in current SP